Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen
Clinical trial NCT01757405 · COMPLETED
Trial details
- NCT number
- NCT01757405
- Sponsor
- Baxalta now part of Shire
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-02-20
- Primary completion
- 2014-11-11
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.